Clinical Trials Browser

Testicular Germ Cell Tumor, Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Carcinoma, Ovarian Epithelial, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neuroblastoma, Ovarian Neoplasms, Sezary Syndrome, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Gestational Trophoblastic Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Clinical Trials

ABLE-41

uPARCRPC

DNA Methylation in Adenocarcinoma of the Prostate: Analysis of Validated Biomarkers in Urine

GENTleMEN

Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer

Contemporary Characteristics of Penile Cancer

Collection of Blood in Studying Metabolites in Patients With Prostate Cancer

Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

PEAR-TREE2

Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations

Study of Rates of Prostate Cancer Diagnosis in Men of African Ancestry Using MRI and MRI Guided Biopsy

Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors

URADJ

Genetic Evaluation of Men (GEM)

Electronic Patient Reported Outcomes in Measuring Health-Related Quality of Life in Patients With Stage I-IV Prostate Cancer Undergoing Treatment

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

ES-HIFU

WB-LuPSMA

Biomarker Identification for Bladder Cancer Patients

Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study).

PSMA-PET/CT Registry

pCHIP: Prostate Cancer Health Impact Program

Immune PDX

OPTIMISE

TRAVELER

Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomy

TRACE

Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease

CREDIT

CHARTER

A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer

In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies

Biomarker Research Study for Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib

MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer

An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital

Transrectal Photoacoustic Imaging of the Prostate

P-PROVE

LCI-GU-BLA-SPEC-001: Aurora Kinase Expression in Muscle-Invasive Bladder Cancer

ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting

Post-marketing Surveillance Regarding Efficacy and Safety of SpaceOAR™

Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate

Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients

Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational Study

Prediction of Response to Kinase Inhibitors Based on Protein Phosphorylation Profiles in Tumor Tissue From Advanced Renal Cell Cancer Patients

Circulating Tumor Cells in Prostate Cancer Patients

PROUD

Genetic Susceptibility to Kidney Cancer

Evaluation of a Blood Biomarker to Try and Distinguish Between the Presence or Absence of Aggressive Prostate Cancer

Von Hippel-Lindau Disease Genetic Epidemiology Study

T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant